{
    "organizations": [],
    "uuid": "e41974439a1c00eeb7d8936631b94b2582c1496c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-evoke-pharma-q4-loss-per-share-002/brief-evoke-pharma-q4-loss-per-share-0-02-idUSASB0C99Y",
    "ord_in_thread": 0,
    "title": "BRIEF-Evoke Pharma Q4 Loss Per Share $0.02",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Evoke Pharma Inc:\n* EVOKE PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND RECENT HIGHLIGHTS\n* Q4 LOSS PER SHARE $0.02 * INCLUDED IN NET LOSS FOR Q4 OF 2017 WAS GAIN OF ABOUT $2.3 MILLION DUE TO CHANGE IN FAIR VALUE OF WARRANT LIABILITY\n* AS OF DECEMBER 31, 2017, COâ€™S CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $7.7 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-08T05:42:00.000+02:00",
    "crawled": "2018-03-08T17:11:57.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "evoke",
        "pharma",
        "inc",
        "evoke",
        "pharma",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "recent",
        "highlight",
        "q4",
        "loss",
        "per",
        "share",
        "included",
        "net",
        "loss",
        "q4",
        "gain",
        "million",
        "due",
        "change",
        "fair",
        "value",
        "warrant",
        "liability",
        "december",
        "co",
        "cash",
        "cash",
        "equivalent",
        "approximately",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}